Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Johns Hopkins Genomics, |
RCV000856679 | SCV000999225 | likely pathogenic | Adrenoleukodystrophy | 2019-05-22 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000856679 | SCV003443998 | likely pathogenic | Adrenoleukodystrophy | 2023-08-24 | criteria provided, single submitter | clinical testing | Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt ABCD1 protein function. This sequence change replaces serine, which is neutral and polar, with phenylalanine, which is neutral and non-polar, at codon 656 of the ABCD1 protein (p.Ser656Phe). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with X-linked adrenoleukodystrophy (PMID: 15811009). ClinVar contains an entry for this variant (Variation ID: 694632). Studies have shown that this missense change alters ABCD1 gene expression (PMID: 15811009). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. |